The aim of this article is to revise the current literature on tendon-derived stem cells for rotator cuff repair. Identification and characterization of a reservoir of progenitor cells in human shoulder periarticular tissues has been successfully confirmed by different authors. The first animal studies on the healing potential of these mesenchymal stem cells showed encouraging results. No clinical trials have been published yet. Rigorous preclinical translational studies are needed to ensure safety and efficacy of stem cells–based treatments before routine use in clinical practice.